Short-term efficacy of angiotensin receptor-neprilysin inhibitor treatment in patients with ST-segment elevation myocardial infarction with reduced ejection fraction after primary percutaneous coronary intervention: a propensity score matching study

Table 2 The Linear regression analysis of Primary cohort

Variable	B	SE	Beta	t	P	95%CI	VIF
ARNI	0.048	0.051	0.069	0.94	0.348	-0.053–0.149	1.088
Age	-0.005	0.004	-0.096	-1.254	0.212	-0.013–0.003	1.186
Sex
Male	Ref
Female	0.1	0.059	0.136	1.704	0.09	-0.016–0.217	1.281
Hypertension
Yes	0.008	0.05	0.012	0.162	0.871	-0.091–0.107	1.059
No	Ref
Diabetes
Yes	-0.086	0.053	-0.115	-1.605	0.11	-0.191–0.02	1.035
No	Ref
Smoking history
No smoking	Ref
Quit smoking	0.063	0.07	0.072	0.893	0.373	-0.076–0.201	1.299
Still smoking	0.072	0.059	0.101	1.228	0.221	-0.044–0.187	1.365
Drinking history
No drinking	Ref
Quit drinking	0.125	0.1	0.093	1.252	0.212	-0.072–0.322	1.109
Still drinking	0.027	0.052	0.039	0.522	0.602	-0.075–0.129	1.133
NT-proBNP	< -0.001	0	-0.046	-0.624	0.534	0	1.11
CTNI	< 0.001	0	0.061	0.82	0.413	0	1.097
β Receptor blocker
Yes	0.062	0.09	0.051	0.694	0.489	-0.115–0.24	1.079
No	Ref
Spironolactone
Yes	-0.079	0.059	-0.097	-1.341	0.182	-0.195–0.037	1.052
No	Ref
Statins
Yes	0.043	0.146	0.021	0.295	0.768	-0.245–0.331	1.063
No	Ref

ISSN: 1471-2261